Details For Selected Brain Tumor Treatment

Sponsored By

Cleveland Clinic Brain Tumor and Neuro-Oncology Center

Please Click On The Above Banner For More Details

Back to New Treatments List


		Treatment Name:		PHASE II, single-arm, open-label investigation of HSPPC-96 vaccine with concurrent temozolomide in patients with newly diagnosed Glioblastoma Multiforme

		Phase:		Phase 2

		Treatment ID#:		1930 081010, C-100-37

		Age Group:		Adults Only

		Min Karnofsky Score:		70: Cares for self, unable to perform normal activity or to do active work

		Conditions:		Prior Surgery is Sometimes Allowed Prior Radiation is Not Allowed Prior Chemotherapy is Not Allowed Newly diagnosed Glioblastoma Multiforme

		Last Updated:		07/07/2009

		Tumor Types:		Glioblastoma Multiforme


		Comments:

		Treatment Type:		Surgery Chemotherapy Radiation Immunological, Biological or Targeted Therapy

		Contact:		Michael Prados MD Professor U. Of California At San Francisco 400 Parnassus Avenue, Rm A808 San Francisco, CA 94143- USA Phone: (415)353-2966 Fax: (415)353-2167 E-mail: pradosm@neurosurg.ucsf.edu Website: neurosurgery.medschool.ucsf.edu/index.html

Last updated refers to the date when our listing for each treatment was last updated.
ID is a combination of our internal ID and the official ID for the trial, if any.
Min Karnofsky is a general guide to how well you have to function to use this treatment

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By